Slideshow
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
This slideshow reviews rucaparib (Rubraca), indicated for the treatment of deleterious BRCA mutation (germline and/or somatic) associated with advanced ovarian cancer who have been treated with 2 or more chemotherapies.
Table of Contents
Slide 4: Dosage and Administration
Slide 10: Cautions, Effects, and Interactions
Slide 17: What to Tell Your Patient
Slide 26: Reference